NS

Nirmala Sahu

Active Director Director DIN 09517614
DIN 09517614 First appointment Feb 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2022
Shareholding value •••• Premium profile

About Nirmala Sahu

Data last updated:

Nirmala Sahu is a Director at Medinovis Lifesciences Private Limited (since 2022). The company operates in Chemicals. Medinovis Lifesciences Private Limited reported revenue of ₹66,100 (FY 2024).

DIN 09517614
Primary Designation Director
Industry Chemicals
First Appointment 23 Feb 2022
Oldest Company Age 4 yrs
Largest company Medinovis Lifesciences Private Limited · ₹66,100 (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Feb 20222022₹66,100 (FY 2024)Active

Directorship timeline

Open interactive timeline →
Medinovis Lifesciences Private Limited
Premium access

Shareholding and investment profile for Nirmala Sahu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nirmala Sahu

Nirmala Sahu currently holds 1 directorship: Medinovis Lifesciences Private Limited (Director, since 23 Feb 2022, revenue ₹66,100 (FY 2024)).

Nirmala Sahu was first appointed on 23 Feb 2022 as Director at Medinovis Lifesciences Private Limited.

The current boards of Nirmala Sahu's companies include Santosh Kumar Mahanty (Medinovis Lifesciences Private Limited), Sumit Kumar Sahoo (Medinovis Lifesciences Private Limited), Swati Sahoo (Medinovis Lifesciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available